Welcome to our dedicated page for SCANSOURCE SEC filings (Ticker: SCSC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SCANSOURCE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SCANSOURCE's regulatory disclosures and financial reporting.
Insider purchase reported by Scansource, Inc. (SCSC). Rachel Hayden, listed as SEVP & CIO and an officer, acquired 2,834 shares of Scansource common stock on 08/21/2025 at a reported price of $0.00 (transaction code A). After the transaction, Hayden beneficially owns 16,008 shares in total. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Stephen Jones, Senior EVP & CFO of ScanSource, Inc. (SCSC), reported a Form 4 disclosing a non-derivative acquisition of 9,421 shares of common stock on 08/21/2025 under transaction code V (vesting). Following the transaction he beneficially owns 79,237 shares. The filing was signed by an attorney-in-fact on 08/25/2025.
Michael L. Baur, who serves as CEO, President and Board Chair of ScanSource, Inc. (SCSC), reported an insider acquisition on 08/21/2025. The Form 4 shows he acquired 25,515 shares of ScanSource common stock with a reported price of $0.00, bringing his beneficial ownership to 158,275 shares after the transaction. The filing was executed on 08/25/2025 by an attorney-in-fact. The disclosure uses transaction code V, and no derivative securities were reported.
ScanSource, Inc. (SCSC) is a technology distributor with two operating segments: Specialty Technology Solutions and Intelisys & Advisory. Net sales for the fiscal year ended June 30, 2025 were $3.04 billion, generated by about 25,000 channel sales partners and roughly 65,000 products from ~500 suppliers. The company operates primarily in the U.S., Canada and Brazil and had approximately 2,100 employees as of June 30, 2025.
Recent developments include acquisitions of Resourcive (Aug 8, 2024) and Advantix (Aug 15, 2024), receipt of $5.9 million in cyber insurance proceeds and recognition of a $6.7 million insurance-related gain in fiscal 2025. The reported effective tax rate for continuing operations was 24.2% in fiscal 2025 and management expects a fiscal 2026 rate of approximately 27.2%–28.2%. Operational metrics: days sales outstanding (DSO) was 70 and inventory turnover reached 5.9x in Q4 FY2025.
ScanSource, Inc. filed a current report to furnish its financial results for the fourth quarter and fiscal year ended June 30, 2025. On August 21, 2025, the company issued a press release and an accompanying earnings infographic outlining these results, which are attached as Exhibits 99.1 and 99.2 and made available on its website.
The exhibits are described as unaudited and intended to be read together with ScanSource’s annual and quarterly reports filed with the SEC. The company also plans to post an updated investor presentation on its website within approximately two weeks of the results announcement.
Scansource, Inc. (SCSC) – Form 4 insider transaction
On 20 June 2025, Rachel Hayden, Senior Executive Vice President & Chief Information Officer of Scansource, Inc., filed a Form 4 disclosing a single open-market sale (Transaction Code “S”) of the company’s common stock executed under a Rule 10b5-1 sales plan adopted 20 March 2025. Hayden disposed of 6,738 shares at an average price of $41.27 per share, representing gross proceeds of roughly $278 k. Following the sale, the executive retains direct beneficial ownership of 13,174 shares of Scansource common stock.
No derivative securities were reported and no other transactions were disclosed in the filing. The transaction does not alter Hayden’s officer status, and there is no indication that the reporting person is no longer subject to Section 16 obligations; the filing was made solely to report the change in beneficial ownership.
The use of a pre-arranged 10b5-1 plan indicates the transaction was scheduled in advance, providing an affirmative defense against insider-trading allegations.
ScanSource, Inc. (SCSC) – Form 144 filing overview
This Form 144 is a notice of a proposed insider sale of 6,738 common shares of ScanSource, Inc., to be executed through Merrill Lynch, Atlanta. The shares have an aggregate market value of $278,077.26, or roughly 0.03 % of the company’s 22.6 million shares outstanding. The transaction is scheduled for 20 June 2025 on the NASDAQ.
The seller acquired the shares through multiple equity-compensation events, including restricted stock unit (RSU) and performance stock unit (PSU) vestings dated between August 2023 and June 2025. No other sales have been reported by this person in the past three months, and no information is provided that would indicate a Rule 10b5-1 trading plan.
The filing is strictly a notice; it does not confirm that the sale has occurred, nor does it disclose the insider’s name, position, or additional context. Given the modest size of the trade relative to shares outstanding and the absence of additional insider activity, the market impact is expected to be limited, though investors may monitor further filings for trend confirmation.